Clinical Trial Update: GC Regimen Chemotherapy Plus CIK Cells for Metastatic Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial evaluating GC regimen chemotherapy plus CIK cells for Stage IV nasopharyngeal carcinoma; the trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• CIK Cells
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Stage IV Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN